News

Covance Inc. (NYSE: CVD http://rd.bcentral.com/?ID=3182929&s=81101478) added to its Phase I capacity and further enhanced its reputation for clinical excellence with the purchase today of GFI Clinical Services from West Pharmaceutical Services, Inc. (NYSE: WST).

Three new customers, including Morphotek Inc., Vitae Pharmaceuticals, Inc. and a medical device subsidiary of a top pharmaceutical conglomerate, signed agreements in July with Phoenix Data Systems to use the company's electronic data capture solutions.

Company Enters Funding Transaction to Support Acquisition Strategy and International Growth.

Dedicated Business Unit Responds to Unmet Need

The Taipei, Taiwan-headquartered biotechnology and pharmaceutical company is now looking for international licensing partners to take the herbal-based product on to further clinical trials and subsequent commercialization.

The closing of the transaction is expected to occur in the third quarter, subject to satisfaction of customary closing conditions, including the regulatory approvals.

Studies Presented at 20th Congress of International Society on Thrombosis and Haemostasis

ICTS Introduces Patient Recruitment Training For Study Coordinators

The European Medicines Agency (EMEA) has launched a six-month consultation period on a draft guideline on the conduct of pharmacovigilance for medicines used by the paediatric population, children from birth to 18 years of age.

Company continues to pioneer new technology and make clinical trials safer, more accurate and efficient.

Newest version of Propack Data PMX MES validation-ready software provides on-demand manufacturing information to help improve productivity, compliance and speed-to-market.

The decision to terminate the partnership follows the recent release of results from Advancis' Amoxicillin PULSYS Phase III clinical trials.

Oxford BioMedica (LSE: OXB), the leading gene therapy company, announced today that the first stage of its Phase II trial in pancreatic cancer with MetXia, the Company's gene targeted prodrug activation product, has been successfully completed.

The Drug Information Association (DIA) today announced a record number of attendees to its 41st Annual Meeting, which took place from June 26-30, 2005 at the Washington Convention Center in Washington, D.C.

Relisys Medical Devices Ltd. announced starting of the International Multi Centre Registry of its new Drug-Eluting Stent.

Tools for Clinical Trials Professionals

Movement to Unify Physician Investigators into One Comprehensive Organization Progresses as ACRP and AAPP Form Official Affiliation

Corporate Compliance Software Helps Hospital Keep Track of Ever-Changing Rules and Regulations

Monitor For Hire will provide Outcome with access to more than 2,000 experienced monitors to support the company's project and data management flow for post-approval studies.

Co-founder of BioMedical Diagnostics, Daniel Pierron, invests alongside Sofimac and BNP Paribas Développement

Achieves 17% Revenue Growth and EPS of $0.05 Versus a Loss in the Prior Year

ICTS To Provide Study Information Websites

MOSS Institute Co., Ltd. announced that its electronic data capture (EDC) system CLASSY fully complies with the U.S. Food and Drug Administration’s (FDA) Part 11 of Title 21 of the Code of Federal Regulations

ClinPhone, the global leader in clinical technology solutions, has introduced its new data center following the successful growth of the business.

Gilead Sciences, Inc. (Nasdaq: GILD) has begun enrolling patients in its Phase III clinical program evaluating the oral antiviral drug tenofovir disoproxil fumarate (tenofovir DF) for the treatment of chronic hepatitis B.

Continuing ICTI’s leadership in Adaptive Clinical Trial Design and Implementation, ICTI’s Manager of Biostatistics, Eva Miller, Ph.D., has been invited to present at the upcoming meeting of the International Society for Analysis, its Applications, and Computation (ISAAC).

Provides Foundation for Comprehensive Drug Development; Marketing Agreement Offers Continuum of Services

Center of Laboratory Medicine, Hua Shan Hospital in Shanghai distinguished as only NGSP Level 1 laboratory in China linked to global clinical trial network